Polyclonal Rabbit anti‑Mouse MSTN / GDF8 / Myostatin Antibody (PE, aa268‑376, WB) LS‑C724133
Polyclonal Rabbit anti‑Mouse MSTN / GDF8 / Myostatin Antibody (PE, aa268‑376, WB) LS‑C724133
Antibody:
MSTN / GDF8 / Myostatin Rabbit anti-Mouse Polyclonal (aa268-376) (PE) Antibody
Format:
Phycoerythrin, Unmodified
Overview
Antibody:
MSTN / GDF8 / Myostatin Rabbit anti-Mouse Polyclonal (aa268-376) (PE) Antibody
Format:
Phycoerythrin, Unmodified
Specifications
Description
Myostatin antibody LS-C724133 is a PE-conjugated rabbit polyclonal antibody to mouse Myostatin (MSTN / GDF8) (aa268-376). Validated for WB.
Target
Mouse MSTN / GDF8 / Myostatin
Synonyms
MSTN | GDF8 | MSLHP | Myostatin | GDF-8
Reactivity
Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Phycoerythrin.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
Cy3,
HRP,
APC,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant MSTN (Asp268-Ser376) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against MSTN.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About MSTN / GDF8 / Myostatin
Featured Products
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human
Applications:
ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Mouse
Applications:
Western blot, ELISA
Species:
Mouse
Applications:
Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/27/2024